Team:Yale/Our Project/Notebook/Week 2

From 2010.igem.org

(Difference between revisions)
m
 
(32 intermediate revisions not shown)
Line 22: Line 22:
<li id="nb"><a href="https://2010.igem.org/Team:Yale/Our Project/Notebook/Week 7">week 7</a></li>
<li id="nb"><a href="https://2010.igem.org/Team:Yale/Our Project/Notebook/Week 7">week 7</a></li>
<li id="nb"><a href="https://2010.igem.org/Team:Yale/Our Project/Notebook/Week 8">week 8</a></li>
<li id="nb"><a href="https://2010.igem.org/Team:Yale/Our Project/Notebook/Week 8">week 8</a></li>
 +
<li id="nb"><a href="https://2010.igem.org/Team:Yale/Our Project/Notebook/Week 9">week 9</a></li>
<li><a href="https://2010.igem.org/Team:Yale/Our Project/Protocols">protocols</a></li>
<li><a href="https://2010.igem.org/Team:Yale/Our Project/Protocols">protocols</a></li>
<li><a href="https://2010.igem.org/Team:Yale/Our Project/Safety">safety</a></li>
<li><a href="https://2010.igem.org/Team:Yale/Our Project/Safety">safety</a></li>
Line 47: Line 48:
<!------------- Monday ------------->
<!------------- Monday ------------->
<h4> Copper Growth Assay Work Continues </h4>
<h4> Copper Growth Assay Work Continues </h4>
 +
<div align="center">
 +
<img src="https://static.igem.org/mediawiki/2010/8/8f/Yale-growthfail.jpg" />
 +
</div>
<ul>
<ul>
<li>As the growth assay of <a href="https://2010.igem.org/Team:Yale/Our_Project/Notebook">6/11</a> showed uniformly poor growth even at the lowest copper concentrations (see Dh5alpha growth above), redid it with care not to let the liquid cultures overgrow, a possible source of the cultures' previous poor performance. (add plot)</li>
<li>As the growth assay of <a href="https://2010.igem.org/Team:Yale/Our_Project/Notebook">6/11</a> showed uniformly poor growth even at the lowest copper concentrations (see Dh5alpha growth above), redid it with care not to let the liquid cultures overgrow, a possible source of the cultures' previous poor performance. (add plot)</li>
Line 67: Line 71:
<!------------- Tuesday ------------->
<!------------- Tuesday ------------->
<h4> Results and Conclusions of Narrow Concentration Range Growth Assay of 6/14</h4>
<h4> Results and Conclusions of Narrow Concentration Range Growth Assay of 6/14</h4>
-
(Show graph)
+
<div align="center">
 +
<img src="https://static.igem.org/mediawiki/2010/d/d1/Yale-dh5alpha-narrow.jpg" />
 +
</div>
<ul>
<ul>
<li> Negative readings for the 4 mM samples suggest that there was some sort of irregularity with the blank solution, so will disregard those results. </li>
<li> Negative readings for the 4 mM samples suggest that there was some sort of irregularity with the blank solution, so will disregard those results. </li>
Line 73: Line 79:
<li>It’s unclear whether the cells at the higher copper concentrations die or simply stop growing.  Spot a drop from each well of the plate onto a LB agar plate and incubate overnight at 37˚C.  Will check for growth to determine survival of different strains at different copper concentrations.</li>
<li>It’s unclear whether the cells at the higher copper concentrations die or simply stop growing.  Spot a drop from each well of the plate onto a LB agar plate and incubate overnight at 37˚C.  Will check for growth to determine survival of different strains at different copper concentrations.</li>
</ul>
</ul>
-
<h4> Plasmid Ligation Strategy & Primer Design </h4>
+
<i>This information is also recorded on page 11 of the hard copy lab notebook. </i> <br/>
 +
<h4> Plasmid Ligation Strategy</h4>
<b> The Plan for phs plasmid creation </b> <br/>
<b> The Plan for phs plasmid creation </b> <br/>
-
The phs operon has three genes of interest to us, A, B, and C, that code for different protein products and together are responsible for hydrogen sulfide production.  We will use these genes to create a number of different plasmids described below.
+
The phs operon has three genes of interest to us, A, B, and C, that code for different protein products and together are responsible for hydrogen sulfide production.  We will use these genes to create a number of different plasmids described below. <br/>
<b> Plasmids to be made: </b> <br/>
<b> Plasmids to be made: </b> <br/>
Plasmid  1 gives our basic thiosulfate reductase pathway under IPTG control.  Plasmid 5 is a light-controlled analog that we will make if we can find a suitable light-inducible promoter.  Plasmid 2 is a promoter-less “generator” to be archived so other teams can use it.  Plasmids 3 & 4 are a set and together give the entire pathway.  The idea is that since protein production takes a while we will make only part of the pathway inducible.  The cell will constitutively produce the A & B products, so after the light hits only the small C protein remains to be made.  <br/>
Plasmid  1 gives our basic thiosulfate reductase pathway under IPTG control.  Plasmid 5 is a light-controlled analog that we will make if we can find a suitable light-inducible promoter.  Plasmid 2 is a promoter-less “generator” to be archived so other teams can use it.  Plasmids 3 & 4 are a set and together give the entire pathway.  The idea is that since protein production takes a while we will make only part of the pathway inducible.  The cell will constitutively produce the A & B products, so after the light hits only the small C protein remains to be made.  <br/>
Line 88: Line 95:
<tr>
<tr>
<td>1</td>
<td>1</td>
-
<td>IPTG-inducible pSB1A2 (well 6G plate 1)</td>
+
<td>IPTG-inducible BBa_R0011(well 6G plate 1)</td>
<td> phsABC </td>
<td> phsABC </td>
<td> BBa_B0015 </td>
<td> BBa_B0015 </td>
<td> pSB1C3 (chloramphenicol resistance)</td>
<td> pSB1C3 (chloramphenicol resistance)</td>
</tr>
</tr>
 +
<tr>
 +
<td>2</td>
 +
<td>none)</td>
 +
<td> phsABC </td>
 +
<td> BBa_B0015 </td>
 +
<td> pSB1C3 (chloramphenicol resistance)</td>
 +
</tr>
 +
<tr>
 +
<td>3</td>
 +
<td>Constitutive BBa_J23114 (well 20I plate 1)</td>
 +
<td> phsAB </td>
 +
<td> BBa_B0015 </td>
 +
<td> pSB1T3 (Tet resistance)</td>
 +
</tr>
 +
<tr>
 +
<td>4</td>
 +
<td>Light-inducible</td>
 +
<td> phsC </td>
 +
<td> BBa_B0015 </td>
 +
<td> pSB1C3 (chloramphenicol resistance)</td>
 +
</tr>
 +
<tr>
 +
<td>1</td>
 +
<td>light-inducible</td>
 +
<td> phsABC </td>
 +
<td> BBa_B0015 </td>
 +
<td> pSB1C3 (chloramphenicol resistance)</td>
 +
</tr>
 +
<tr>
</table>  
</table>  
 +
*This plan was eventually altered, as promoter choices were altered and no light-inducible promoter was found. <br/>
 +
<br />
 +
<div id="right">
 +
<img src="https://static.igem.org/mediawiki/2010/7/71/Yale-biobrick.jpg" />
 +
</div>
 +
To make these plasmids, we will rely on the standard iGEM assembly protocol involving restriction enzymes EcoRI, XbaI, PstI, and SpeI shown in the diagram at right, but in the first ligation the B0015 terminator will take the place of C0010 and the phsABC  gene in pSB74 will take the place of B0034. <br/>
 +
 +
<b> Steps to make these plasmids </b> <br/>
 +
1. Initial Amplification—transform and amplify terminator, promoter, and gene DNA <br/>
 +
2. Gene-Terminator linkage—Digest terminator with EcoRI and XbaI, digest PCR product gene  with EcoRI and SpeI, and ligate together to get gene and terminator in nonstandard plasmid <br/>
 +
3. Creation of Standard Generator—digest step 2 product with EcoRI and PstI and ligate into standard iGEM plasmid pSB1C3 to get the generator <br/>
 +
4.  Addition of promoter—Digest promoter with EcoRI and Spe--digest generator vector with EcoRI and XbaI, and ligate together<br/>
 +
 +
<h4> Primer design for PCR amplification of the phsABC gene from background vector pSB74 </h4>
 +
Given the size of phsABC,  introducing it in pieces with AB on one plasmid and C on a second might enhance expression. For this purpose, we have designed forward primers that include the EcoRI and XbaI cut sites and an RBS to go at the beginning of A and C as well as reverse primers with a SpeI site to go at the end of B and C. <br/>
 +
The following primers were designed based on the phsABC sequence information (see below) after having confirmed that the BioBrick restriction enzyme cut sites are not present in the phsABC sequence. <br/>
 +
 +
N-terminal primer for phsABC: 5’ GCA GAATTC GCGGCCGC T TCTAGA G AGGAGGTTTAT ATG AGC ATT AGT CGT CG <br/>
 +
C-terminal primer for phsAB: 5’ AGC ACTAGT A TCA TGC TTT ACC CTC CTG ATG GAC <br/>
 +
N-terminal primer for phsC: 5’ GCA GAATTC GCGGCCGC T TCTAGA G AGGAGGTTTAT ATG AAT ACT ATC TGG GG <br/>
 +
C-terminal primer for phsABC: 5’ AGC ACTAGT A TCA GAC GGC GGA CTT ATC CCC <br/>
 +
 +
<a id="link" href="javascript:ReverseDisplay('sequence')">See/hide phsABC sequence </a>
 +
<div style="display:none;" id="sequence">
 +
 +
<!------------- sequence data------------->
 +
phsA STM2065 <br/>
 +
>sp|P37600|PHSA_SALTY Thiosulfate reductase OS=Salmonella typhimurium GN=phsA PE=3 SV=2 <br/>
 +
MSISRRSFLQGVGIGCSACALGAFPPGALARNPIAGINGKTTLTPSLCEMCSFRCPIQAQ VVNNKTVFIQGNPSAPQQGTRICARGGSGVSLVNDPQRIVKPMKRTGPRGDGEWQVISWQ QAYQEIAAKMNAIKAQHGPESVAFSSKSGSLSSHLFHLATAFGSPNTFTHASTCPAGKAI AAKVMMGGDLAMDIANTRYLVSFGHNLYEGIEVADTHELMTAQEKGAKMVSFDPRLSIFS SKADEWHAIRPGGDLAVLLAMCHVMIDEQLYDASFVERYTSGFEQLAQAVKETTPEWAAA QADVPADVIVRVTRELAACAPHAIVSPGHRATFSQEEIDMRRMIFTLNVLLGNIEREGGL YQKKNASVYNKLAGEKVAPTLAKLNIKNMPKPTAQRIDLVAPQFKYIAAGGGVVQSIIDS ALTQKPYPIKAWIMSRHNPFQTVTCRSDLVKTVEQLDLVVSCDVYLSESAAYADYLLPEC TYLERDEEVSDMSGLHPAYALRQQVVEPIGEARPSWQIWKELGEQLGLGQYYPWQDMQTR QLYQLNGDHALAKELRQKGYLEWGVPLLLREPESVRQFTARYPGAIATDSDNTYGEQLRF KSPSGKIELYSATLEELLPGYGVPRVRDFALKKENELYFIQGKVAVHTNGATQYVPLLSE LMWDNAVWVHPQTAQEKGIKTGDEIWLENATGKEKGKALVTPGIRPDTLFVYMGFGAKAG
 +
AKTAATTHGIHCGNLLPHVTSPVSGTVVHTAGVTLSRA <br/><br/>
 +
 +
>phsA <br/>
 +
atgagcattagtcgtcgttcttttttgcagggggtaggcatcggctgctctgcctgcgcg ctgggcgcttttccgcccggggcgctggcgcgcaacccgattgccggcattaacggtaaa accacgctaacgccaagcttgtgcgaaatgtgttcctttcgttgccctattcaggcgcag gtagtcaataacaagaccgtttttatccagggcaatccttctgcgccgcagcaggggacg cgcatatgcgccaggggcgggagcggcgtcagcctggtcaatgacccgcaacggattgta aaacctatgaaacgcaccgggccacgcggcgacggtgaatggcaggtgattagctggcaa caggcttaccaggaaatcgcggcgaaaatgaatgccatcaaagcgcagcatggccccgag agcgtggctttctcttccaaatcgggctcgctctccagccatcttttccatctggctacg gcctttggttcgcctaatacctttacgcacgcctcaacatgccctgccgggaaagccatt gcggcaaaagtgatgatgggcggcgatctggcgatggatatcgctaacacgcgctatctg gtttcgtttggccacaatttgtatgaagggattgaagttgccgatacccatgagttaatg accgcgcaggagaagggggccaaaatggtgagcttcgatccgcgtttgtcgatattttcc agcaaggcggatgagtggcacgctattcgtcccgggggggatttagcggttctgctggcg atgtgccacgtcatgattgatgaacagctctacgatgcgtcttttgttgagcgttatacc agcggatttgaacagttagcacaggcggtaaaagagacgacgccggaatgggccgccgcg caggccgatgtcccagccgacgttattgtccgggtgacacgcgaactggctgcctgcgcg cctcacgctattgtcagtcctggtcatcgcgcgacgttctcgcaggaagagatcgatatg cggcgtatgatttttacgcttaatgtgctgctcggtaatattgagcgcgaaggcgggcta tatcagaaaaaaaacgcgtctgtttacaataaactggccggagaaaaggtcgcgccaacg ctggcgaaactcaacattaaaaatatgccgaaaccgacggcgcaacgcatcgatttggtc gcaccgcagtttaaatatatcgccgctggcggcggcgtggtgcaaagcattattgactcg gcgttaacccagaagccttacccgataaaggcgtggattatgtcgcggcataatcctttc cagaccgtcacctgtcgttcggacctggtaaaaaccgttgagcaactggatctggtggtc agctgcgatgtctatttgagcgagagcgcggcatatgccgactatctgctgccggaatgc acctatctcgaacgggacgaagaggtatccgatatgtcgggactgcacccggcttacgct ctgcgccaacaggtcgtagagccgattggcgaggcgcgtccgagttggcaaatctggaaa gaacttggcgagcagttgggattagggcagtactatccgtggcaggatatgcagacgcgc caactctatcagttgaacggcgaccatgccttagcgaaggaactgcgacagaaagggtat ctcgaatggggcgttccgctgctattacgcgaaccagaatccgttcgtcagtttacggcg cgttaccccggcgctatcgcgacggacagtgacaacacctatggcgaacagcttcgcttc aaatcgccctccggcaaaatcgaactttattccgcaaccctggaggaattgctccctggc tacggcgttccgcgcgttcgtgactttgcgctgaaaaaagagaatgagctttacttcatt cagggcaaggtggccgtgcataccaatggcgcgacgcagtacgtacctttactcagcgag ctaatgtgggataacgcggtctgggttcatccgcaaacggcgcaagaaaaaggcattaag accggcgatgagatctggctggaaaatgccacgggtaaagagaaaggtaaggcgctggtg acgcccggtatccgcccggacacgctttttgtctatatgggatttggcgctaaagctggg gccaaaacggcggcgacgacacacggtatccactgcggaaatttactgccgcacgtgacg agtccggtatccggtacggtagtgcataccgcaggcgtgacgctgagccgggcatga <br/><br/>
 +
 +
phsB STM2064 <br/>
 +
>sp|P0A1I1|PHSB_SALTY Thiosulfate reductase electron transport protein phsB OS=Salmonella typhimurium GN=phsB PE=4 SV=1 <br/> MNHLTNQYVMLHDEKRCIGCQACTVACKVLNDVPEGFSRVQVQIRAPEQASNALTHFQFV RVSCQHCENAPCVSVCPTGASYRDENGIVQVDKSRCIGCDYCVAACPFHVRYLNPQTGVA DKCNFCADTRLAAGQSPACVSVCPTDALKFGRLDESEIQRWVGQKEVYRQQEARSGAVSL
 +
YRRKEVHQEGKA <br/><br/>
 +
 +
>phsB <br/>
 +
Atgaatcatttaacgaatcagtacgtcatgctgcatgatgaaaaacgttgtatcggctgc
 +
caggcgtgtaccgttgcctgcaaagtgcttaatgacgtaccggagggatttagccgcgta
 +
caggtacaaattcgcgcccctgaacaggcatccaacgcactaacccattttcaatttgtc
 +
cgcgtctcctgtcagcactgtgaaaatgcgccatgtgtcagcgtttgtcctaccggagcg
 +
tcatatcgtgatgaaaacgggatcgtgcaggtggataaatcgcgctgtattggctgcgat
 +
tattgtgttgccgcgtgtcctttccatgtgcgctatttgaatccgcaaaccggtgtcgcc
 +
gacaagtgtaacttctgcgccgacacgcggttggcggctggccagtctccggcgtgcgta
 +
tccgtttgcccaacggacgcgctgaaattcggcagactggatgagagcgagatccagcgc
 +
tgggtcggtcagaaagaggtctatcgccagcaggaggcgcgtagcggcgcggtcagtctg
 +
taccgtcgtaaagaagtccatcaggagggtaaagcatga <br/><br/>
 +
 +
phsC STM2063 <br/>
 +
>sp|P37602|PHSC_SALTY Thiosulfate reductase cytochrome B subunit OS=Salmonella typhimurium GN=phsC PE=4 SV=2 <br/>
 +
MNTIWGAELHYAPDYWPLWLIYAGVVVLLMLVGLVIHALLRRMLAPKTAGGEEHRDYLYS LAIRRWHWGNALLFVLLLLSGLFGHFSLGPVALMVQVHTWCGFALLAFWVGFVLINLTTG NGRHYRVNFSGLVTRCIRQTRFYLFGIMKGEAHPFVATEQNKFNPLQQLAYLAIMYALVP LLIITGLLCLYPQVAGLGPVMLVLHMALAIIGLLFICAHLYLCTLGDTPGQIFRSMVDGY
 +
HRHRTAPRGDKSAV <br/><br/>
 +
 +
>phsC <br/>
 +
Atgaatactatctggggagcggaactacattatgcgccagattattggccgctgtggttaa
 +
tttacgcaggcgtcgtggtgctgctcatgcttgttgggctggttatccatgcgttattgcg
 +
ccggatgctggcgccaaaaacggcgggcggtgaagaacatcgtgactatctctactcgctg
 +
gcgattcgccgctggcattggggaaatgcgttactgtttgttttattactgttaagcggtt
 +
tatttggtcatttttctctcggccctgtagcgctaatggtacaagtgcatacctggtgtgg
 +
ttttgccttactggctttctgggtcgggtttgtgctgatcaacctcaccacaggtaacggg
 +
cgtcactatcgggtaaatttttccggactggtaacgcgctgcatacgccagacgcgttttt
 +
acctttttggcattatgaaaggggaagcgcatccgttcgtggcaacagagcagaataagtt
 +
caatccactgcaacaactggcatatctggcgattatgtacgcgctggtaccgctgttaatc
 +
atcaccggtttgctgtgtctctatccgcaggttgcgggtctgggccctgtgatgctggtgc
 +
tgcatatggcgcttgctatcatcggcttactgtttatttgcgcgcatctctatctgtgtac
 +
tcttggcgacacgccgggacaaattttccgtagcatggttgacggctatcatcgtcatcgt
 +
accgcgccgcgcggggataagtccgccgtctga <br/>
 +
 +
 +
<!------------- sequence data------------->
 +
</div>
 +
<br/>
Line 101: Line 211:
<li>
<li>
-
Wednesday 6/16--checked on spotted cell survival assay, collected MOPS minimal media materials, started making component solutions
+
Wednesday 6/16--Checked on spotted cell survival assay, collected MOPS minimal media materials & started making component solutions
</li>
</li>
Line 108: Line 218:
<!------------- Wednesday ------------->
<!------------- Wednesday ------------->
-
Extra content
+
<b> Minimal Medium Work </b> <br/>
 +
In Jay Keasling's work with thiosulfate reductase he used a variation of MOPS minimal medium designed to avoid background metal presence from interfering with measurement of bacterial metal removal potential. Began making the various necessary component solutions as detailed in this <a href="https://2010.igem.org/Team:Yale/Our_Project/Protocols/minimal_medium">recipe </a> <br/>
 +
<b>Survival of bacteria in copper growth assay </b> <br/>
 +
Previously had plated a drop of each culture from the narrow concentration range copper growth assay on 6/14 to see if the cultures that had stopped growing/never grew were still alive.  Observed the following results, where g signifies growth and - signifies no growth:<br/>
 +
<table>
 +
<tr>
 +
<td>cell line</td>
 +
<td>0 M Cu<sup>2+</sup></td>
 +
<td>500 uM Cu<sup>2+</sup></td>
 +
<td>600 uM Cu<sup>2+</sup></td>
 +
<td>700 uM Cu<sup>2+</sup></td>
 +
<td>800 uM Cu<sup>2+</sup></td>
 +
<td>900 uM Cu<sup>2+</sup></td>
 +
<td>1 mM Cu<sup>2+</sup></td>
 +
<td>1.5 mM Cu<sup>2+</sup></td>
 +
<td>2 mM Cu<sup>2+</sup></td>
 +
<td>3 mM Cu<sup>2+</sup></td>
 +
<td>4 mM Cu<sup>2+</sup></td>
 +
<td>1 M Cu<sup>2+</sup></td>
 +
</tr>
 +
<tr>
 +
<td>DH5alpha</td>
 +
<td>- </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>- </td>
 +
<td>g </td>
 +
<td>- </td>
 +
<td>- </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>- </td>
 +
</tr>
 +
<tr>
 +
<td>LE392</td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>g </td>
 +
<td>- </td>
 +
</tr>
 +
</table>
 +
It is unsurprising that all cells should die at 1 M copper sulfate concentrations, but the lack of growth of DH5alpha at 0 M, 900 uM, etc. seems anomalous, given that the cells clearly survived at higher copper levels and may reflect an insufficient amount of culture spotted in those cases. <br/>
 +
<i>This information is also recorded on page 11 of the hard copy lab notebook. </i> <br/>
<!------------- Wednesday ------------->
<!------------- Wednesday ------------->
</div>
</div>
Line 121: Line 283:
<!------------- Thursday ------------->
<!------------- Thursday ------------->
-
Extra content
+
<b>Modified MOPS minimal medium</b><br/>
 +
Finished creation of a stock solution according the this <a href="https://2010.igem.org/Team:Yale/Our_Project/Protocols/minimal_medium">recipe </a> <br/>
 +
<b>Additional <i> E. coli </i> strain </b> <br/>
 +
Began a culture of BL21 as another hardy option for future assays. <br/>
<!------------- Thursday ------------->
<!------------- Thursday ------------->
</div>
</div>
<li>
<li>
-
Friday 6/18--plasmid pSB74 arrived (!), already in some unspecified E coli, so plated them out. Transformed promoters (constitutive & IPTG inducible), terminator, and repressor (for inducible promoter) into BL21. Also ran BL21 copper growth assays for wide and narrow concentrations ranges.
+
Friday 6/18--Arrival of plasmid pSB74, transformation of Biobricks, & copper growth assays for BL21 strain.  
-
June the 19th--in which it is revealed that there was a transformation-fail
+
-
Redid transformation, this time into LE392, set aside pSB74 containing cells in fridge
+
</li>
</li>
Line 134: Line 297:
<div style="display:none;" id="friday">
<div style="display:none;" id="friday">
<!------------- Friday ------------->
<!------------- Friday ------------->
-
Extra content
+
<ul>
 +
<li>Plasmid pSB74, which contains the thiosulfate reductase gene, arrived from Addgene, already in some unspecified <i>E coli</i>, so plated them out on an ampicillin LB plate and put in incubator at 37.</li>
 +
<li>Transformed constitutive promote J23114, IPTG-inducible promoter R0011, terminator B0015, and repressor C0012(for inducible promoter) into BL21 according to standard <a href="https://2010.igem.org/Team:Yale/Our_Project/Protocols/transformation">transformation protocol </a> and plated onto ampicillin LB plates</li>
 +
<li>Also ran BL21 copper growth assays for wide and narrow concentrations ranges according to the modified protocol used on 6/14, starting with dilution of a culture of OD 0.873.</li>
 +
</ul>
 +
<i> The activities of this day are also recorded on pages 13-15 of the hard copy lab notebook </i>
<!------------- Friday ------------->
<!------------- Friday ------------->
</div>
</div>
Line 140: Line 308:
<li>
<li>
-
Sunday 6/20--in evening inoculate 5 mL liquid cultures
+
Saturday 6/19--Redo of Biobrick transformations & analysis of BL21 copper growth assay
</li>
</li>
<a id="link" href="javascript:ReverseDisplay('sunday')">See more/less</a>
<a id="link" href="javascript:ReverseDisplay('sunday')">See more/less</a>
<div style="display:none;" id="sunday">
<div style="display:none;" id="sunday">
-
<!------------- Sunday ------------->
+
<!------------- Saturday ------------->
-
Extra content
+
<b>Transformation troubles</b> <br/>
-
<!------------- Sunday ------------->
+
While the pSB74 culture grew, none of the BL21 transformants from 6/19 did, so repeated the transformations of Biobricks B0015, R0011, C0012,and J23114 into LE392 cells, once again following this <a href="https://2010.igem.org/Team:Yale/Our_Project/Protocols/transformation">transformation protocol</a> and plating onto ampicillin LB plates. The remaining transformant solutions were set aside in case of another failure.<br/>
 +
<b>BL21 copper growth assay analysis</b> <br/>
 +
Retrieved the following data regarding BL21's growth in copper solution: <br/>
 +
<div align="center">
 +
<img src="https://static.igem.org/mediawiki/2010/f/f6/Yale-bl21.jpg" />
</div>
</div>
 +
It appears that BL21 is slightly more sensitive to copper than the other two strains, since 3 mM levels of copper(II) sulfate are enough to almost completely inhibit BL21's growth. <br/>
 +
<i> The activities of this day are also recorded on page 15 of the hard copy lab notebook </i>
 +
<!------------- Saturday ------------->
 +
</div>
 +
 +
 +
<li>
 +
 +
Sunday 6/20--Observed growth of  all transformants from 6/19, so used them and the culture containing pSB74 to inoculate 5 mL liquid cultures in LB with ampicillin.  Left to grow overnight on shaker at 37˚C for miniprep the following morning. <br/>
 +
<i> The activities of this day are also recorded on page 16 of the hard copy lab notebook </i>
 +
 +
</li>
 +
<!------------- LAB NOTEBOOK ------------->
<!------------- LAB NOTEBOOK ------------->

Latest revision as of 02:49, 28 October 2010

iGEM Yale

lab notebook: week 2 (6/14-6/20)

  • Monday 6/14--Redo of 6/11 assay of bacterial growth within a narrow copper(II) concentrations after analysis of data showed uniformly poor growth.
  • See more/less
  • Tuesday 6/15--Results and analysis of the 6/14 narrow concentration range growth assay as well as planning for the creation of a standard iGEM plasmid bearing the thiosulfate reductase operon (phsABC).
  • See more/less
  • Wednesday 6/16--Checked on spotted cell survival assay, collected MOPS minimal media materials & started making component solutions
  • See more/less
  • Thursday 6/17--more minimal media work and meeting, started BL21 culture
  • See more/less
  • Friday 6/18--Arrival of plasmid pSB74, transformation of Biobricks, & copper growth assays for BL21 strain.
  • See more/less
  • Saturday 6/19--Redo of Biobrick transformations & analysis of BL21 copper growth assay
  • See more/less
  • Sunday 6/20--Observed growth of all transformants from 6/19, so used them and the culture containing pSB74 to inoculate 5 mL liquid cultures in LB with ampicillin. Left to grow overnight on shaker at 37˚C for miniprep the following morning.
    The activities of this day are also recorded on page 16 of the hard copy lab notebook